Shilan Ding
Beijing, 100700, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Triptonide Suppresses AML via PI3K/AKT Signaling: A Network Pharmacology Approach Validated by Molecular Docking and Experimental Studies.
Journal: Current issues in molecular biology
Published: December 28, 2025
Verbenalin protects against coronavirus pneumonia by promoting host immune homeostasis: Evidences for its mechanism of action.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 19, 2024
Corrigendum: D-dencichine regulates thrombopoiesis by promoting megakaryocyte adhesion, migration and proplatelet formation.
Journal: Frontiers in pharmacology
Published: September 30, 2024
Evodiamine: A Extremely Potential Drug Development Candidate of Alkaloids from Evodia rutaecarpa.
Journal: International journal of nanomedicine
Published: January 13, 2024
Synergistic effect of cucurbitacin E and myricetin on Anti-Non-Small cell lung cancer: Molecular mechanism and therapeutic potential.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 23, 2021
Inhibition of Shear-Induced Platelet Aggregation by Xueshuantong via Targeting Piezo1 Channel-Mediated Ca2+ Signaling Pathway.
Journal: Frontiers in pharmacology
Published: October 13, 2020
The Joint Effect of a Combination of Components From the Fruit of Crataegus pinnatifida Bge. Var. major N.E. Br. and the Root of Salvia miltiorrhiza Bge. With Exercises on Swimming in Focal Cerebral Infraction in Rat.
Journal: Frontiers in physiology
Published: June 20, 2020
Preparation of RGD Peptide/Folate Acid Double-Targeted Mesoporous Silica Nanoparticles and Its Application in Human Breast Cancer MCF-7 Cells.
Journal: Frontiers in pharmacology
Published: March 26, 2020
D-dencichine Regulates Thrombopoiesis by Promoting Megakaryocyte Adhesion, Migration and Proplatelet Formation.
Journal: Frontiers in pharmacology
Published: October 14, 2017
Notoginsenoside R1 ameliorates diabetic encephalopathy by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation.
Journal: Oncotarget
Published: September 19, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026